Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for trans individuals is effective and generally safe in the short term.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

A woman developed male characteristics after using unregulated hormone therapy.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hormone therapy can improve sexual health and quality of life for women 70 and older.

Hormone replacement therapy improves skin health and reduces aging signs in postmenopausal women.

Hormonal contraceptives and therapies regulate organ functions and treat various conditions.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Properly monitored hormone therapy can improve life quality, but misuse can cause serious health issues.